To further determine the pharmacological potential of these agents, their time-dependent effects on IL-8 expression and secretion were analyzed with the aim of identifying compounds that exhibit selectivity toward specific CRC cell lines that represent various stages of tumor progression. The gene discussed is CXCL8; the disease is neoplasm.